Lixte Biotechnology Holdings Inc

NASDAQ LIXT

Data sourced from iex and EODHD
Download Data

Lixte Biotechnology Holdings Inc Income Statement 2006 - 2024

This table shows the Income Statement for Lixte Biotechnology Holdings Inc going from 2006 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 - - - - - - - - - - -
Cost of Revenue
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 - - 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 - - - - - - - - - - -
Operating Expenses
M - - - - - - - - - - - - - - - - - - - - - 0 1 0 0 0 0 0 1 1 - - 1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - 0 - - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 1 1 0 0 0 0 0 -
Research and Development (R&D) Expenses
M 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Other Operating Expenses
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 - - 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Costs and Expenses
M - - - - - - - - - - - - - - - - - - - - - 0 1 0 0 0 0 0 1 1 1 1 0 1 1 0 1 1 1 1 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Operating Income
M -1 -1 -1 -2 -1 -2 -1 -2 -2 -2 -1 -2 -2 -1 -2 0 0 0 -1 -1 0 0 -1 0 0 0 0 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 0 0 0 0 0 -1 0 -1 -1 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 -1 0 -1 0 0 0 0 0 0
Interest Expense
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - -
Non-operating Income/Expense
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -3 -1 0 0 -1 0 0 0 -1 0 0 0 -1 0 0 0 -2 0 0 0 -3 0 0 0 -1 0 0 -
EBT
M -1 -1 -1 -2 -1 -2 -1 -2 -2 -2 -1 -2 -2 -1 -2 0 0 0 -1 -1 0 0 -1 0 0 0 0 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 0 0 0 0 -4 -2 -1 -1 -2 -1 0 0 -1 0 0 0 -2 0 0 0 -1 0 0 -1 -2 -1 0 0 0 0 0 -
Income Tax Provision
M -1 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - 0 0 0 0 0 0 0 0 0 - - - - - - 0 0 - 0 0 - - - - -3 0 0 - -1 0 - - -1 - - - -1 - - - -1 - - - -1 - - - 0 0 0 0
Income after Tax
M 0 -1 -1 -2 -1 -2 -1 -2 -2 -2 -1 - - - - - - - - - - 0 -1 0 0 0 0 0 -1 -1 - - - - - - -1 -1 - -1 -1 - - - - 0 -2 -1 - -1 -1 - - 0 - - - -1 - - - 0 - - - 0 - - - 0 0 0 -
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Net Income
M - - - -2 -2 -2 -1 -2 -2 -2 -1 -2 -2 -1 -2 0 0 0 -1 -1 0 0 -1 0 0 0 0 0 -1 -1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 2,249,290.00 2,249,290.00 2,074,938.00 1,665,956.00 1,664,951.00 1,665,567.00 1,664,659.00 1,620,091.00 1,374,659.00 1,374,960.00 1,373,391.00 1,363,304.00 1,276,820.00 1,158,562.00 1,117,430.00 1,117,430.00 1,117,430.00 1,117,606.00 1,117,430.00 1,117,430.00 1,117,430.00 1,018,392.00 967,154.00 967,097.00 967,097.00 967,503.00 966,933.00 961,300.00 823,856.00 797,930.00 797,930.00 797,930.00 797,930.00 798,128.00 767,676.00 778,500.00 758,309.00 758,248.00 758,051.00 750,304.00 693,051.00 693,051.00 693,051.00 693,051.00 693,051.00 693,369.00 692,640.00 623,740,000.00 588,679,000.00 5,861,579,000.00 587,653,000.00 584,654,000.00 584,620,000.00 5,846,208,000.00 584,620,000.00 584,620,000.00 561,565,000.00 4,909,702,000.00 490,970,000.00 488,654,000.00 472,915,000.00 4,655,372,000.00 465,537,000.00 465,537,000.00 465,024,000.00 4,451,263,000.00 443,540,000.00 443,037,000.00 443,037,000.00 4,358,753,000.00 435,875,000.00 318,125,000.00 45,000,000.00
EBITDA
M -1 -1 -1 -2 -1 -2 -1 -2 -2 -2 -1 -2 -2 -1 -2 0 0 0 -1 -1 0 0 -1 0 0 0 0 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 0 -1 0 0 0 0 -2 0 0 -1 -1 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 -1 0 -1 0 0 0 0 0 0
Depreciation and Amortization
M 1 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 0 - - - - - - - - - - - - - - - - - - 0 0 - 0 0 0 0 0 0 -1 1 0 - - 0 - - - - - - 0 - 0 0 0 0 0 0 0 0 0 0 0 0 0 -
EBIT
M -2 -1 -1 -2 -1 -2 -1 -2 -2 -2 -1 -2 -2 -1 -1 0 0 0 -1 -1 0 0 -1 0 0 0 0 0 -1 -1 -1 -1 0 -1 -1 -1 -1 -1 -1 -1 -1 0 0 0 0 0 -1 0 -1 -1 0 -1 - - - - - -1 - 0 0 0 0 0 -1 0 -1 0 0 0 0 0 -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 99.54 0.10 0.10 0.05 -0.10 0.32 0.18 0.02 0.00 0.00 0.01 - - - - - - - - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - - - - - - 0.00 0.00 - 0.00 0.00 - - - - 92.30 0.00 0.00 - 67.59 0.00 - - 117.91 - - - 62.89 - - - 79.41 - - - 81.88 - - - 65.53 -45.92 -21.53 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 73.69 100.00 - - - - - - - - - - - - - - - - - - - - - - - - - - - 100.00 - - - - - - - - - - -
Operating Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -208.28 -306.93 - - - - - - - - - - - - - - - - - - - - - - - - - - - -7,504.78 - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -208.28 -306.93 - - - - - - - - - - - - - - - - - - - - - - - - - - - -7,500.69 - - - - - - - - - - -
EBIT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -208.27 -306.93 - - - - - - - - - - - - - - - - - - - - - - - - - - - -7,504.78 - - - - - - - - - - -
EBT Ratio
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -208.27 -306.93 - - - - - - - - - - - - - - - - - - - - - - - - - - - -36,611.63 - - - - - - - - - - -

StockViz Staff

September 16, 2024

Any question? Send us an email